Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.
Why this paper is included
Supporting source evidence:
Feeding practices at baseline and throughout the study period (n = 200)VariablesExperimental Group (n = 100)n(%)Control group (n = 100)n(%)t / χ2 valueP value aType of milk Exclusive breast feeding (month old) 0 to 5.99100 (100)100 (100)−0.630.53 Mean ± SD4.51 ± 0.564.65 ± 0.59 Still breastfeeding (month old) At 5.9990 (90)96 (96)2.760.09 At 11.9968 (68)64 (64)0.350.65 At 17.994 (4)3 (3)1 † Mean ± SD11.57 ± 3.3511.76 ± 2.19−0.430.66 Infant formula (month old) Birth: 5.9967 (67)70 (70)0.200.64 6 to 11.9971 (71)76 (76)0.640.42 12 to 17.9988 (88)81 (81)1.870.17 Fresh milk (month old) Birth: 5.9960 (60)56 (56)0.320.56 6 to 11.9947 (47)50 (50)0.180.67 12 to 17.9987 (87)93 (93)20.15 Milk powder (other than infant formula) (month old) Birth: 5.997 (7)5 (5)0.350.55 6 to 11.9967 (67)55 (55)3.020.08 12 to 17.9983 (83)90 (90)2.090.14 Others (month old) Birth: 5.991 (1)0 (0)1 † 6 to 11.990 (0)1 (1)1 † 12 to 17.9911 (11)14 (14)0.410.52Age at introduction of complementary foods Foods Commercial cereals65 (65)6.25 ± 0.7968 (68)6.05 ± 0.841.300.19 Porridge/Rice52 (52)6.61 ± 0.9655 (55)6.77 ± 1.01−0.760.44 Biscuits/Breads100 (100)5.59 ± 0.81100 (100)5.79 ± 0.84−1.550.12 Hen egg63 (63)8.90 ± 0.669 (69)9.02 ± 0.70−0.910.36 Meat/Fish30 (30)12.28 ± 1.4335 (35)12.08 ± 1.330.530.59 Vegetables90 (90)6.89 ± 1.2789 (89)7.05 ± 1.34−0.710.47 Fruits100 (100)7.48 ± 1.43100 (100)7.35 ± 1.420.560.57 Drinks Water with sugar52 (52)4.10 ± 0.6258 (58)4.14 ± 0.61−0.330.74 Fruit juice75 (75)5.44 ± 0.8577 (77)5.18 ± 0.741.840.06 Tea35 (35)5.63 ± 0.8441 (41)5.50 ± 0.740.690.48 Coffee2 (2)12.5 ± 1.411 (1)12 ± 0.000.280.82 Others99 (99)8.80 ± 0.9496 (96)8.87 ± 0.95−0.460.64aStatistical testing using independent samples t-test or chi-square test†Fisher’s exact test*Difference is significant at p < 0.05 (2-tailed)**Difference is significant at p < 0.01 (2-tailed)Baseline characteristics of the participated infants in the two groupsbCharacteristicsExperimental group (n = 100)Control group (n = 100)P valueaHousehold characteristics Family size (n)5.85 ± 2.355 ± 1.770.33 Family income (NIS)c1275 ± 818.061000 ± 724.310.07 Number of under-five children (n)2.01 ± 0.762 ± 0.520.18Maternal characteristics Age (years)28..41 ± 5.8628.4 ± 5.100.70 Body mass index26.54 ± 5.3326.64 ± 4.360.19 Mother’s education (years)13.18 ± 2.8912 ± 3.010.54 Mother’s working status (%)0.07 Working6 (6)15 (15) Housewives94 (94)85 (85)Infants’ characteristics Age (months)6.28 ± 0.106.24 ± 0.090.08 Gender (%)0.86 Male52 (52)51 (51) Female48 (48)49 (49) Birth weight (kg)3.44 ± 0.333.41 ± 0.320.55 Gestational age (weeks)38.31 ± 0.7138.37 ± 0.680.59 Infant currently breastfeeding (%)92 (92)96 (96)0.31Anthropometric measures Weight (kg)7.57 ± 0.797.65 ± 0.720.47 Length (cm)66.20 ± 1.8766.11 ± 1.920.75 Weight-for-age (z score)−0.12 ± 0.920.01 ± 0.930.47 Length-for-age (z score)−0.25 ± 0.85− 0.28 ± 0.970.79 Weight-for-length (z score)0.11 ± 1.010.28 ± 1.250.35Biochemical measure Blood hemoglobin (g/dl)11.42 ± 0.3511.44 ± 0.370.78Energy and micronutrient intakes Total energy (kcal/day)656 ± 164696 ± 1670.11 Iron (mg/day)7.51 ± 7.407.90 ± 8.550.75 Vitamin A (mcg/day)299.70 ± 120.31264.32 ± 161.190.10 Vitamin D (mcg/day)3.24 ± 2.63.85 ± 3.030.16*Difference is significant at p < 0.05 (2-tailed)aStatistical testing using independent samples t-test or chi-square testbValues are reported as means±SDcNIS New Israeli Shekel
Source: Results. View original paper
Relevance classification does not establish study quality, causation or editorial approval.
Study design Randomised controlled trial.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Meta-analysis unclear · Blinding unclear / not reported · Human research reported
How this paper was classified
Automatic source-based classification; awaiting editorial verification. This is not a quality score.
This randomized controlled trial was conducted in two health care clinics of the UNRWA at the middle area governorate of Gaza Strip, Palestine.
Source: Methods.
The study was approved by the Helsinki Ethics Committee of Gaza Strip, as well as the Ethics Committee for Research Involving Human Subjects (JKEUPM) of the Faculty of Medicine and Health Sciences, Universiti Putra Malaysia.
Source: Methods.
What the study types mean
- Systematic review
- Uses explicit methods to identify, assess and summarise research on a defined question.
- Scoping review
- Maps the extent and characteristics of research on a topic.
- Narrative review
- Discusses existing research; systematic-review methods have not been established by this classification.
- Review / evidence synthesis
- Reviews existing research; the exact review methods need further assessment.
- Randomised controlled trial
- Assigns participants or groups to comparison interventions by chance.
- Non-randomised intervention study
- Examines an intervention without random allocation.
- Cohort study
- Examines exposures and outcomes over time within a defined group.
- Case-control study
- Compares people with an outcome against people without it, examining exposures.
- Cross-sectional study
- Examines a population at a particular point in time.
- Observational study
- Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
- Case report
- Describes an individual case.
- Case series
- Describes a group of individual cases.
- Secondary analysis
- Analyses existing study data; this paper is not automatically another independent trial.
- Laboratory study
- Investigates biological processes in a laboratory setting.
- Qualitative study
- Examines experiences or meanings using qualitative methods.
- Genetic instrumental-variable study
- Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
- Study protocol
- Describes planned methods and is not evidence that the planned study has reported results.
- Multiple reported designs
- More than one design is explicitly reported; examine the supporting methods.
- Study design awaiting verification
- The available source does not establish a sufficiently clear study design.
Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.
Abstracts
Multiple micronutrient supplementation improves growth and reduces the risk of anemia among infants in Gaza Strip, Palestine: a prospective randomized community trial
Randomised controlled trial · Nutrition Journal · 2020
Original publication title
Multiple micronutrient supplementation improves growth and reduces the risk of anemia among infants in Gaza Strip, Palestine: a prospective randomized community trial
© The Author(s) 2020
Original publication · Publisher record · CC BY 4.0 · CC0
Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.
At a glance
Abstract: What background does the paper provide?
Infants and young children 6 to 24 months of age are the most nutritionally vulnerable groups, as their needs for vitamins and minerals are high relative to the amount of food they consume. This study determines the effect of Micronutrient Powder Supplementation (MNP) on growth and hemoglobin of infants in Gaza Strip, Palestine.
Source: BackgroundAbstract: What methods does the paper describe?
This was a two-arm parallel-group randomized controlled trial conducted in two health care clinics of the United Nations Relief and Work Agency (UNRWA) at the Middle Area governorate of Gaza Strip, Palestine. A total of 200 healthy infants aged 6-month-old were recruited and randomized to receive 3 sachets/week of MNP for 12 months alongside with the National Micronutrient Supplement (NMS) (n = 100) or NMS alone (n = 100). Weight, length, blood hemoglobin, and dietary intakes were measured at 6, 9, 12, 15, 18, and 21 (3 months after the end of intervention) months of age.
Analysis was by intention to treat.
Source: MethodAbstract: Results
The experimental group had a higher concentration of hemoglobin at 12 and 15 months than did the control group, and a significant difference (p < 0.05) was observed at 15 months only. Significantly greater weight, length, weight-for-age, length-for-age, and weight-for-length z-scores were observed in the experimental group than that in the control group at 12 and 15 months (p < 0.05). The prevalence of anemia (18% vs. 52%) and stunting (1% vs. 11%) were higher in the control than the experimental group, respectively.
After controlling for sex, similar findings were reported.
Source: ResultsAbstract: Conclusions
Addition of MNP to the existing NMS program improved the nutritional status of young children. The potential benefits of MNP supplementation on physical growth and hemoglobin should be considered in the existing NMS program.
Source: ConclusionsAuthors’ abstract
Background
Infants and young children 6 to 24 months of age are the most nutritionally vulnerable groups, as their needs for vitamins and minerals are high relative to the amount of food they consume. This study determines the effect of Micronutrient Powder Supplementation (MNP) on growth and hemoglobin of infants in Gaza Strip, Palestine.
Method
This was a two-arm parallel-group randomized controlled trial conducted in two health care clinics of the United Nations Relief and Work Agency (UNRWA) at the Middle Area governorate of Gaza Strip, Palestine. A total of 200 healthy infants aged 6-month-old were recruited and randomized to receive 3 sachets/week of MNP for 12 months alongside with the National Micronutrient Supplement (NMS) (n = 100) or NMS alone (n = 100). Weight, length, blood hemoglobin, and dietary intakes were measured at 6, 9, 12, 15, 18, and 21 (3 months after the end of intervention) months of age.
Analysis was by intention to treat.
Results
The experimental group had a higher concentration of hemoglobin at 12 and 15 months than did the control group, and a significant difference (p < 0.05) was observed at 15 months only. Significantly greater weight, length, weight-for-age, length-for-age, and weight-for-length z-scores were observed in the experimental group than that in the control group at 12 and 15 months (p < 0.05). The prevalence of anemia (18% vs. 52%) and stunting (1% vs. 11%) were higher in the control than the experimental group, respectively.
After controlling for sex, similar findings were reported.
Conclusions
Addition of MNP to the existing NMS program improved the nutritional status of young children. The potential benefits of MNP supplementation on physical growth and hemoglobin should be considered in the existing NMS program.
Trial registration
ISRCTN57594793; Date of registration: 20-03-2018 (Retrospectively registered).
Publication and source details
Original title: Multiple micronutrient supplementation improves growth and reduces the risk of anemia among infants in Gaza Strip, Palestine: a prospective randomized community trial
Ali Albelbeisi; Zalilah Mohd Shariff; Chan Yoke Mun; Hejar Abdul Rahman; Yehia Abed
Nutrition Journal · 2020
© The Author(s) 2020https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.Repository JATS snapshot; version as supplied
Source retrieved: 2026-11-12T13:54:48.697185+00:00
DOI: 10.1186/s12937-020-00652-7 · PMC7719238